GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...
With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
Hosted on MSN5mon
Boost for GlaxoSmithKline as US jury rules heartburn drug did not cause a woman's cancerAn American jury handed GlaxoSmithKline (GSK) a boost by deciding its discontinued heartburn drug did not cause a woman’s cancer. The UK pharmaceutical giant prevailed when it was decided that ...
healthday on MSN11d
FDA Adds Warning Label to RSV Vaccines Abrysvo and ArexvyThe U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing informa ...
24 Jul, 2018 11 Sep, 2018 1:1 For every 1 share held; Holder will receive 1 bonus shares. 28 Sep, 1994 02 Jan, 1995 1:1 For every 1 share held; Holder will receive 1 bonus shares. 23 Jun, 1980-1:3 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback